Archer form partnership for At-home testing device for Kidney disease.

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02930313-2A1587646&v=7bc42bd11d853ed5e8c28f2ffcd6a069ee5cd6b4

Disc: Hold IRL & SM

CEO departing for personal reasons. Announced on a Friday after close. Shock, doom and gloom discussion on HC (key person risk) but some consider it an appropriate time to find a CEO to move from research to commercialisation. Some lead time, January departure which is less worrying.

"announces the departure of Dr Mohammad Choucair as Chief Executive Officer (“CEO”). Mohammad will step down from the CEO role in January 2025 to ensure a smooth transition and handover. Mohammad retires from the Company for personal reasons, and the Board wishes Mohammad and his family the best for the future."

“Mohammad was a co-inventor of our advanced technology projects, leading the Company on a stronger future. With the transition to a semiconductor company, Mohammad has led the biggest transformation in the Company’s history and has set Archer up for a strong future,” 

“After nearly 7 years with Archer, I am proud of my contribution in transitioning the Company from a mineral explorer to a semiconductor company. The Company is in a good position, and I feel it is the right time to step down as CEO. " Dr Choucair.

After 7 months of tumble weeds, Archer appears to have made great progress with its 12CQ Chip.

Archer have stated that they will provide greater details this week. 

Link to full announcement on the ASX.

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02788256-2A1513590

Coming of a low base, but happy with the 26% uplift today.

I know Mo and the team are really busy, however would love to get Mo back for another chat, if possible, @Strawman

Disc hold IRL & SM

I can't find any news on this 35% jump. with excessive volumes and some pretty big orders lined up

Archer transfers biochip graphene sensor technology design to a commercial fab to verify scalability

Highlights

• Archer Materials has successfully completed a proof of concept biosensing graphene transistor for use in its biochip.

• The design has been submitted to a commercial foundry for a Multi-Project Wafer run

. • Fabrication at commercial foundries to verify the scalability of Archer’s design will occur in coming months with delivery of chips expected by the end of 2023

. • Archer has started discussions with potential global foundry partners for initial small production runs of its graphene chip designs to evaluate the reliability of the product.

• This is a major step towards the potential commercialisation of Archer’s biochip technology. 

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02686290-2A1461008?access_token=83ff96335c2d45a094df02a206a39ff4

Would love to get Mo back at some point and provide an update.

Hold IRL & SM

Quite Achievers

ASX Announcement (ASX: AXE) 20 June 2023

Archer achieves qubit material functionality at room temperature in air Highlights

• Archer Materials has engineered its qubit material to mimic a high vacuum environment, preserving quantum functionality at room temperature in air.

• The semiconductor fabrication process is foundry-compatible and has the potential for technology translation to industrially scale Archer’s 12CQ qubit chip architecture

. • The preservation of quantum coherence in Archer’s qubit material at room temperature in air demonstrates a significant advantage over qubit proposals that are difficult to integrate onboard modern day devices

. • Archer’s unique qubit material is conveniently made from carbon, yet robust enough to generate quantum states for long enough times needed for quantum logic operations

. • Archer Materials is the only ASX listed company and one of a few players in the world developing qubit processor technology. 

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02677708-2A1455650?access_token=83ff96335c2d45a094df02a206a39ff4

Disc Hold

Third Quarter Activities Report and Appendix 4C For the three months ending 31 March 2023

Significant Activities

• The Company is well capitalised with approximately $24.4 million cash and no debt.

• 12CQ chip development advances to wafer-scale quantum electronic device fabrication using foundry-compatible UV optical and E-beam lithography

. • Hundreds of quantum electronic devices and qubit materials prepared for testing, measurement, integration, and optimisation towards qubit control and readout.

• Engagement with tier-one semiconductor companies, including TSMC, to secure future manufacturing capabilities and support technology development.

• Biochip technology milestone achieved, overcoming a conventional limitation of gFET sensing that paves the way to the selective detection of target molecules

. • The Company is actively and regularly pursuing exposure to international global semiconductor industry participants.

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02656556-2A1444717?access_token=83ff96335c2d45a094df02a206a39ff4

Don't Personally feel like $24 Million is a lot of money in this sector.

Nice to see us working with market leaders TSMC

Disc Hold IRL & SM

Second Quarter Activities Report and Appendix 4C 

Archer Materials Provides Activities Report - A busy back end to last year, Can't wait to see what Mo and the team can achieve moving forward in 2023.

Significant Activities

• The Company is well capitalised with approximately $24.3 million cash and no debt

. • Significant advances made in 12CQ chip development, with some of the most powerful supercomputers in the world used to validate the 12CQ chip qubit material uniqueness

. • Major milestone achieved towards commercialisation of Archer’s biochip technology, with the development and custom-build of an operational, early stage end-to-end prototype system platform

• IP protection sought nationally and internationally for several biochip related patent applications, spanning molecular biology, wettable graphene transistors, and sensing system platforms.

• The Company is actively and regularly pursuing exposure to international global semiconductor industry participants.

https://cdn-api.markitdigital.com/apiman-gateway/CommSec/commsec-node-api/1.0/event/document/1410-02622775-7CM4FVCQKVODQ9UHLMSVKE2M8Q/pdf?access_token=00074KEloiYnuFsfTg1fopkKwg9E

Disc Hold IRL and SM.

I found this YouTube clip regarding Archer, it was shared on another platform,It's about 3 months old.

https://www.youtube.com/watch?v=NvnQj1WGcbA

Love the way Mo talks about how they see themselves as disruptors and the possible applications moving forward.

When we talk about good management, this guy seems to be the real deal for me.

Excited by the future.

Disc Hold IRL and SM.

Another Price Sensitive announcement from Archer

Powerful supercomputers validate 12CQ qubit material uniqueness

Highlights

- Some of the most powerful supercomputers have been used to pinpoint the origins of a key tech-enabling quantum phenomena observed in the 12CQ qubit material.

• The supercomputer analysis is a first, providing the most accurate simulations of Archer’s unique 12CQ qubit material, confirming a metallic-like nanocarbon

. • Archer will use the simulations to support the design and development of complex quantum electronic devices required for the future operation of the 12CQ chip

.• Archer is the only ASX listed company and one of a few players in the world developing qubit processor technology.

https://cdn-api.markitdigital.com/apiman-gateway/CommSec/commsec-node-api/1.0/event/document/1410-02601140-303R6R06JFL2I6C6BLV1SPCM5C/pdf?access_token=00070dmlg5LC3zZlsAg2md8wlOwd

Hold IRL & SM

Slowly making way to potential profitability.

Early-stage prototype of biochip system platform

Highlights

• In a major milestone towards biochip commercialisation, Archer has

implemented an integrated system platform for biosensing.

• Archer will use the biochip platform for quickly testing in-house biosensing

chips to obtain the relevant data for establishing commercial partnerships.

• The current system hardware and software paves the way for future designs

that embed single-chip multiplexing.

• Global semiconductor companies see sensors representing semiconductor

products with the greatest growth opportunity in the industry†.

• The biochip technology is being developed in-house by Archer staff and Archer

owns 100% of the related intellectual property.

https://cdn-api.markitdigital.com/apiman-gateway/CommSec/commsec-node-api/1.0/event/document/1410-02598595-4UC08K0HRPO87HTL3VKE171TP4/pdf?access_token=0007Ljq7FEBRxA5rzwn5VTgRuyUb

Disc hold IRL and SM

I listened to an interesting presentation by Archer (ASX:AXE) this morning and thought I’d share the notes I took. This includes the Q&A at the end.

Presentation slides as announced on the ASX

I do think Archer (ASX:AXE) is on to something great, but as with most things I invest in, it may take half a dozen years to be commercialized and reach its inflexion point.

From the presentation:

Archer is one of VERY FEW companies developing Qubit processors, and the only one listed on the ASX.

12CQ chip has unique advantages - particularly its suitability for hand-held/mobile devices - This is a competitive advantage.

World first is that the 12CQ chip operates at room temperature (normal conditions)

The current device is the result of over a decade of R&D

This is an emerging technology. There is still more to be done, and they are doing it.

Quantum computing will impact EVERY technology that relies on computing power. Especially industries relying on growing computing power.

Immense power even with a single cubit quantum computer.

Existing technology cannot solve many of man’s problems, and those it can solve it takes too damned long. As in centuries of processing.

Securing and protecting information is one important area. Qubit-based processing is a potential solution to encryption keys that are generated randomly and cannot be guessed.

Other work - Graphene based Bio Chip/ chip on a lab

Miniaturized bio-laboratoriy involving atom-thin technology.

Shrinking an entire lab onto a chip that can fit on your fingernail.

Leads to faster analysis time.

Huge barriers to entry in this field, but Archer has made some significant advances using Graphene transistors as ultrasensitive sensors to detect and analyze disease.

Questions:

1) When do you think you will be able to have the product for customers to start using quantum computing?

We do have a commercial plan and do have R&D plan.

We are well within what we , and others in the industry expect.

Can’t give a prescriptive answer. Can’t be held to specific timelines.

2) Can Australia develop its own industry here?

Building a fab costs billions of dollars. That probably isn’t on the cards. But here are smaller scale set-ups that allow you to do a lot, but not large scale production.

3) How difficult was it to get the 12CQ chip onto CMOS and where did you manufacture it.

Nothing is easy. It was very difficult and took a long time with a dedicated team.

Using CMOS is a BIG deal.

Fabricated over at TSMC.

4) Where are you getting Graphene from and is it expensive?

I know how to make it because I was the first person to do so.

You can buy Graphene off the shelf or make it yourself using Ethanol.

Processes on how to produce production levels of Graphene is in the R&D pipeline.

5) How did you get into the IBM ecosystem?

We were invited in.

6) Can you talk about main challenges ahead? What is the key thing that keeps you awake WRT developing the IP.

There’s no set precedent with any of this work. There’s no Google search and there’s no back of the envelop stuff you can do from the work of others.

We need to solve every problem by ourselves.

It’s a brand new technology and is difficult to convince all necessary stake holders to get involved.

7) Why don’t you share your IP so others can come on board and add to it?

Protect IP first. That’s my answer!

Once your IP is protected then you can do as you will with opening up.

8) A recent report came out regarding building up the Australian semiconductor industry. What are your thoughts on how to get this up and running in Aust.

Can we do it - Yes, absolutely, we have the talent.

There are the right people who have the ability to see it through. We need commitment to fund it.

We need to concentrate on niches that we can excel in, and differentiate ourselves in.

We can already do this at a port-typing level within Australia. But not at production level.

Some of this Tech is above me - Archer Continuing Positive advancements.

https://cdn-api.markitdigital.com/apiman-gateway/CommSec/commsec-node-api/1.0/event/document/1410-02586600-7ID8JLVOJ6L6RR505LV7P744V1/pdf?access_token=0007QyRjVfVbHfrBD3ST6XvHNgXq

First Quarter Activities Report -

Progressing well

https://cdn-api.markitdigital.com/apiman-gateway/CommSec/commsec-node-api/1.0/event/document/1410-02585767-3JP6GCNQOH9JRON7KFICE0QS8H/pdf?access_token=0007FytXMqyOIlTApt5lZXVtYqdL

Hold IRL and SM

This announcement is HUGE! I agree completely with the sentiment expressed by Mohammad Choucair in that “The significance of the work . . . cannot be understated”

The following announced this morning:

Quantum information detected using a CMOS chip

Archer Materials Limited (ASX: AXE) is pleased to announce that the Company for the first time has used complementary metal–oxide–semiconductor (“CMOS”) chip technology to detect quantum information in the 12CQ qubit material at room temperature.

Highlights:

• Step-change advance in Archer’s 12CQ chip development with quantum information detected in its qubit material at room temperature using CMOS technology.
• CMOS is a widely used semiconductor technology for building the chips found in most modern-day devices.
• Integrating Archer’s 12CQ qubit material with CMOS technology provides a potential pathway for the development of practical quantum-enabled mobile devices.
• Archer is the only ASX listed company and one of a few players in the world developing qubit processor technology.

CMOS is the predominant technology used in designing chips in the semiconductor industry and it is broadly used today to form integrated circuits in numerous and varied applications. Processors, memory, and sensors are among many electronic devices that make use of this technology. The use of CMOS technology in the semiconductor industry is expected to continue in the long-term therefore, it is important to demonstrate the functional incorporation of the 12CQ qubit material with CMOS devices.

In a major technological feat, Archer has now used a single-chip integrated electron spin resonance detector based on CMOS technology to detect the quantum spin states in the as-prepared 12CQ qubit material in a controlled atmosphere at room temperature. The quantum states were found to be sufficiently well preserved when operating in the on-chip environment.

Commenting on the 12CQ chip progress, Archer CEO Dr Mohammad Choucair said: “The significance of the work to realise a CMOS chip that successfully detects the quantum spin states in our qubit material at room temperature cannot be understated and represents a step-change technological achievement in advancing Archer’s 12CQ quantum chip development.

“A key advantage of the new CMOS chip is that the componentry is made using standard and commercially available semiconductor fabrication technology.

“This achievement builds on the considerable progress Archer has made this year in the design and development of the 12CQ chip, which all link to the future operation of the technology.”

@slymeat Also good news that the foundry is outside of China, especially with current tension.

Well, well well. I received the following newsletter today. Things certainly seem to be stepping up in the world of room temperature quantum computers, let alone the world of wearable/mobile quantum devises—both of which Archer and its 12CQ chip can achieve. Now they have a significant foundry involved. Way to go Archer!

Mass produced quantum processors. That will be a world first.

Newsletter copied below:

Archer and GlobalFoundries to advance 12CQ chip fabrication

Archer Materials Limited (ASX: AXE) is pleased to announce it will work with a world-leading semiconductor foundry, GlobalFoundries® (“GF®”) (“NASDAQ: GFS”), to advance the development of its 12CQ quantum chip technology (“12CQ chip”).

Highlights:

• Archer has commenced working with GlobalFoundries towards industry fabrication of its 12CQ quantum chip technology.
• GlobalFoundries is a world-leading semiconductor foundry, providing Archer with expertise, equipment, and manufacturing processes to develop the 12CQ chip.
• Archer is the only ASX listed company and one of few players in the world developing qubit processor technology.

Archer’s innovation aims to integrate its unique qubit material with mobile-compatible devices that are in a form suitable for industrial-scale semiconductor nanofabrication. To scale the fabrication of Archer’s 12CQ chip devices and components, the Company will need to work with industrial-scale manufacturers in the global semiconductor supply chain (ASX ann. 21 Jul 2022).

Archer will access the technology facilities and manufacturing processes of GlobalFoundries® to explore pathways for potential high-volume manufacturing of 12CQ chip devices and components. Archer will work closely with GlobalFoundries® on device and circuit design, technology development, and high-volume chip fabrication.

Current quantum computing qubit architectures rely on custom made fabrication, unlike modern classical computing circuits that are manufactured in, and using, well-established industrial semiconductor facilities. Integrating qubit materials with existing industrial-scale foundries is a significant challenge in developing quantum processors.

Commenting on the semiconductor supply-chain link with GlobalFoundries®, Archer CEO Dr Mohammad Choucair said: “Archer is now positioned to leverage the expertise and capabilities of a tier-one semiconductor manufacturer to accelerate the development of the 12CQ quantum computing chip technology.”

Archer achieves its targeted goal of sub-10 nanometre (nm) feature size fabrication, in a major tech development breakthrough for the Company. 

https://cdn-api.markitdigital.com/apiman-gateway/CommSec/commsec-node-api/1.0/event/document/1410-02560983-3459UUDNHIBQDPEODI6KTQ8TFE/pdf?access_token=0007Z6lENegZJlXPu6JOwds0Ebpf

Disc Hold IRL & SM

Archer Materials (AXE) receives Hong Kong approval for their 12CQ quantum computing chip.

I believe this was the last pending patent.

https://cdn-api.markitdigital.com/apiman-gateway/CommSec/commsec-node-api/1.0/event/document/1410-02552423-5DORBR7APFQ37OBB2LM54RIEAT/pdf?access_token=0007i6kXjc1FgSjPVt6kQRLVWPrD

Looking forward to seeing what the future holds.

Disc held IRL and SM

Archer continuing to achieve it's strategic goals.

Archer biochip progresses towards sub-10 nanometre fabrication

Archer-biochip-progresses-towards-sub-10nm-fabrication.PDF

Disc - Held IRL & SM.

Patent Approval for Australia Granted.

Just Hong Kong to go (I think)

Australian-patent-granted-for-12CQ-quantum-computing-chip.PDF

Held

Archer's quarterly reports are out

Activities

CashFlow

Activities see great progress in 12CQ development, some interesting staff hires, and a well needed brief on the lab-on-a-chip. See I knew they weren't being a one-horse show!. They are still progressing other research too.

Of great interest is their achievement of single-atom-thick-Graphene—I didn;t know that had been achieved by anyone yet. But not only that, integrtaing it with silicon. A major milestone on this project.

In the CashFlow report - they have zero debt and ample cash to see them through for many quarters.

It all looks very promising. But don;t be scared to give these couple of pages a read for yourself.

SmallCaps interview with CEO of Archer, Mohammad Choucair on the 12CQ technology.

This interview is well worth the 9 minutes it takes to watch it. Choucair is so excited about this technology, and his excitment is infectious.

The interview is titled “Archer Materials’ quantum chip technology paving way for quantum-powered mobiles”. Choucair’ ‘s reveal of a physical device, that exists today, that can do quantum computing in a mobile device, may get overlooked by many, but I am completely blown away by it.

https://www.youtube.com/watch?v=lnY2cpY7RZo

The written article can be found at

https://smallcaps.com.au/archer-materials-advances-development-quantum-chip-technology/

Interesting fact: Choucair, at the tender age of 23, was the first person in the world to chemically make Graphene at bulk levels. What an interesting chap!

What an impressive CV he has. And then there is also the other amazing talent employed by Archer. Choucair mentions some of them in the interview.

With Choucair running the show, I don‘t think Quantum Computing will be the only quantum technology that comes out of Archer. There’s already their Lab on a Chip, but I expect even more.

Choucair goes on to my very small list of CEOs I care to listen to. He tells things straight.

Archer out with a fabulous announcement today. It is wonderful to see they are still progressing their “biochip” project. I see so much merit in that.

But the thing that astounds me about their most recent announcement is that they are using atom-thin Graphene. I thought that was still only theoretical, but here they are, not only producing it but using it with purpose.

I even love the way they call it “atom-thin” rather than atom-thick of single layer Graphene. It really hammers home how thin it actually is.

Archer truly are at the bleeding edge. Exactly where I love to invest.

Electron transfer achieved in atom-thin Graphene.

Archer Materials European patent granted for 12CQ quantum computing chip

European-patent-granted-for-12CQ-quantum-computing-chip.PDF

Disc - Hold IRL and SM

Quantum information detected using mobile compatible chip technology

A collaboration with EPFL in Switzerland has seen quantum information detected at room temperature on mobile compatible chip technology. This appears to be a step in the right direction towards quantum computing powered mobile devices.

Again, this technology isn't something I have taken a deep dive into, does anyone here have any insight into QC?

The company also announces it has $29M in cash and no corporate debt.

Up 15% to $1.24 on this news but still well below last CR price of $1.45

https://archerx.com.au/src/uploads/2022/02/20220201_Quantum-information-detected-using-mobile-compatible-chip-ASX-Release.pdf

CQF

AXE as of 14/1/22: a substantial holder of CMX = voting power of 12.75%

https://chemxmaterials.com.au/about/

We Are ChemX Materials

We are an advanced materials technology company. ChemX has developed a proven process to produce High Purity Alumina (HPA) – a critical input for battery technology.

Disc': RL & S.M

Graphene integrated with silicone electronics

This announcement from Archer Materials is focused on their biotech project (lab-on-a-chip).

They have announced that they have integrated single atom-thick graphene to silicone wafer which is significant progress toward development of a biochip which analyses biological specimens on a nano scale. The company states that the biochip could be used to "enable the complex detection of some of the world's most communicable diseases".

I won't pretend that I have a deep knowledge of this space, I would love for anyone who does to chime in and offer any analysis on this emerging technology.

The announcement is an interesting read, not difficult with some imagination to come up with some interesting use cases.

I bought a small position IRL and SM a while ago for some speculative exposure to the quantum computing/nanotech space.

https://archerx.com.au/src/uploads/2022/01/20220113_Graphene-integrated-with-silicon-electronics-ASX-Release.pdf

CalmQuietFocus

Graphene integrated with silicon electronics

Highlights

• Archer addresses a key nanotech challenge in its biochip development by successfully integrating single atom-thick graphene on a silicon wafer
• . Archer intends to use graphene as an ultrasensitive sensor for detecting and analysing diseases.
• The biochip has been developed in-house by Archer staff and Archer owns 100% of the biochip technology intellectual property.  

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02475306-2A1351139?access_token=83ff96335c2d45a094df02a206a39ff4

Disc: I hold

SPP closes early  - Company Increases from $5 Million to $10 Million due to over subscribed.

Early-stage validation of qubit robustness

Highlights

• Robustness of qubit coherence validated for the first time in an inert atmosphere at room temperature.

• The work demonstrates a significant advantage over competing room- temperature qubit proposals that rely on high vacuum environments, such as ion-traps, that are difficult to integrate onboard mobile devices.

• Archer is well-funded to progress its 12CQ chip technology development after recently raising A$15 million via an institutional placement.

• Archer is the only ASX listed company and one of a few players in the world developing qubit processor chip technology in the semiconductor industry†.

Archer Materials Limited (“Archer”, the “Company”, “ASX: AXE”) is pleased to provide shareholders with a technical progress update on Archer’s 12CQ quantum computing chip technology (“12CQ chip”).
The Company for the first time validated that the qubits’ quantum coherence properties‡ are preserved under an inert atmosphere. Quantum coherence is the fundamental requirement for quantum logic operations that are the basis of any quantum computing qubit processor hardware. For potential integration and use of qubit materials in practical chip devices, it is significant to demonstrate and validate qubit robustness at room temperature and under atmospheric environments other than that of air or vacuum.
Qubit robustness further validates potential use in on-board mobile devices
The measurements to validate the qubit robustness were performed at room temperature using state-of-the-art electron spin resonance (“ESR”) instruments in Sydney, Image 1. Bulk quantities of Archer’s qubit material were subjected to an inert atmosphere comprising nitrogen gas, a commonly used and abundant gas that makes up 78% of air, which was found to preserve the qubits’ quantum coherence properties.
Other inert atmospheres that may preserve the qubits’ quantum properties are now subject to ongoing, routine optimisations of the external qubit environment by the Archer team.
Archer also found that the quantum properties of the bulk qubit material could be recovered even after the qubit material experienced shelf-lives exceeding years, and when placed under extreme exposure to high temperatures for at least several weeks (i.e. the qubit material withstood exceptional degradation conditions that are possible in chip-based environments).

A$15 million raised through successful placement to domestic and global institutional investors.

Archer this morning has announced that it has received firm commitments for A$15 million via an institutional placement of 10.3 million new fully paid ordinary shares. This gives the company funds to pursue the development of their 12CQ chip. Share price is down about 7% as of 12pm.

The company says that the funds will be used for the following:

• Progressing Archer’s world-first technology development, including its 12CQ chip and Biochip.
• Utilising world-class technology development infrastructure and facilities, R&D, people, and IP, to support pre-market development of Archer’s technologies.
• Protecting intellectual property assets (e.g. patents and international patent applications) underpinning the Company’s technology.
• Establishing and strengthening new and existing commercial partnerships in Australia and abroad.
• General working capital requirements.

Highlights:

• Successful completion of a A$15 million placement at A$1.45 per share.
• Non-underwritten Share Purchase Plan to be offered to eligible investors to raise up to a further A$5 million.
• Funds raised will be primarily used to develop Archer’s 12CQ quantum computing chip and lab-on-a-chip biochip technologies.
• Funds will also enable the Company to pursue further technology and commercial development in the US.

DISC: Held currently.

Trading Halt over the long weekend.

Thinking Cap Raise.

US Patent granted.

AXE Quantum Computing + ITech IPO

Fundamentals:

Market Cap:  $454Mill

Fully Paid Ord. Shares $227.7Mill

Price $2.00

Cash: Operating cash flow / Total tangible assets: zero%

Total liabilities / Total tangible assets: Ok buoyant at 0.025

Net Debt / equity:  -37%

Total available funding 30th June 2021:  $6,239Mill

Estimated quarters of funding available : 9.9 Quarters =  6,239 / 631

Note: no Dividend  paid so no Gordon  Analysis here.

 https://archerx.com.au/our-business

How

Location: Offices Adelaide, Sydney

The board: Dr Mohammad Choucair

Chief Executive Officer

Bio

Dr Choucair was the first person in the world to directly synthesise graphene (the thinnest material known) in gram-scale quantities as a bulk powder - now a common goal amongst researchers. Subsequently, the work was identified by the Royal Society of Chemistry as one of the biggest chemical breakthroughs of 2008, and in 2011 Dr Choucair received the coveted Cornforth Medal from the Royal Australian Chemical Institute. Dr Choucair is currently developing a nanoscale device as part of a quantum computer that could be capable of indirectly addressing problems associated to human health and the environment. He invented the carbon material that formed the basis of the device. Dr Choucair has also been actively involved in the enhancement of lithium ion battery storage devices and demonstrated some of the first examples of graphene application in batteries. In addition, Dr Choucair has synthesised a novel class of metal-decorated fullerenes ('fullerides') that were capable of reversible hydrogen storage with potential applications in hydrogen fuel cells and industrial catalysis. Dr Choucair was recognised by Virgin Australia as one of the Top Australian Stars of 2016, honouring people from diverse fields who showed excellence, dedication, ambition and community-mindedness in offering new perspectives on seemingly intractable problems. Dr Choucair is currently serving a 2-year mandate as Councillor on the World Economic Forum's Global Future Council for Advanced Materials. Dr Choucair is now involved with the Council in drafting aspects related to Advanced Materials in The Global Risks Report.

Mr Gregory David English: Executive Director,Executive Chairman (Since 2015)

Bio:

Mr English has more than 25 years of engineering and legal experience and has held roles for Australian and multinational companies. Greg is an company director and also serves on the boards of other ASX listed companies. He is a memberof the Risk Management Committee.

Other current directorships

Non-Executive Chairman,Non-Executive Director CXO Core Lithium Ltd

Gregs Current holding : 18Mill shares

WHY THIS idea?

Quantum computing represents the next generation of powerful computing. A qubit processor is the most crucial hardware component of a quantum computer.

Archer is developing a qubit processor chip, that could potentially operate at room temperature and integrate into modern electronics.

Current quantum computing technologies are limited in ownership and use because they use qubit processors that can only operate at low temperatures and/or are difficult to integrate in modern electronics.

The successful development of Archer’s 12CQ room-temperature qubit processor chip could potentially provide a breakthrough solution to the widespread use and ownership of quantum computing powered technology, owing to the unique materials properties of the 12CQ chip.

The 12CQ qubit processor chip is being built by the Archer team in Sydney, Australia, in a world-class semiconductor foundry with an ISO Class 5 Level cleanroom housing state-of-art nanofabrication instrumentation. The work is led by Archer CEO and 12CQ inventor Dr Mohammad Choucair, and Archer’s Quantum Technology Manager Dr Martin Fuechsle, the inventor of the single-atom transistor. The 12CQ chip is based on work published in the prestigious journal Nature Communications, and patent application filed in Australasia, the EU, and US.

WHY NOW?

Australia has a critical mass of expertise in quantum computing and is at the forefront of the industry. There are currently very few publicly listed companies that offer exposure to financial returns from quantum computing technology.

The quantum computing industry forms a niche but quickly growing part of the global half-a-trillion-dollar semiconductor industry, which generates the highest value in investment returns through the step-change development of technology and underlying intellectual property.

Successful commercialisation of Archer’s 12CQ qubit processor chip technology could catalyse the global quantum computing industry by servicing existing and emerging consumer markets reliant on increased computational power like artificial intelligence (AI) and blockchain technologies like digital currencies.

KEY MILESTONES WE AIM TO ACHIEVE

Our strategy is to develop a qubit processor chip that can be directly sold and the intellectual property rights to the chip technology sublicensed by:

De-risking the technology by building a room-temperature operational qubit processor chip prototype. Development involves assembling and testing chip components by applying a deep understanding of nanotechnology, materials chemistry, and quantum physics.

Establishing partnerships with highly resourced organisations in the semiconductor industry. Commercial development involves prosecuting patent applications in Australasia, Europe and the US, to provide the commercial freedom to operate in these markets.

Peers :

Best Quantum Computing Stocks To Buy [Or Sell] Now

• Nvidia Corporation (NASDAQ: NVDA)
• Amazon.com Inc. (NASDAQ: AMZN)
• Applied Materials Inc. (NASDAQ: AMAT)
• International Business Machines Corporation (NYSE: IBM)
•  

Ref: https://www.fool.com/investing/stock-market/market-sectors/information-technology/ai-stocks/quantum-computing-stocks/

Why Invest?

Quantum computers are continually improving and becoming more affordable to develop, and the advent of cloud computing is making quantum technology even more accessible for researchers and software developers. Computing power needs are ballooning as the digital economy expands, with spending on global cloud computing alone predicted to rise to $1 trillion annually within the next decade. Quantum computing could emerge as a key technology in the years ahead

When

2021 is likely to be a year where quantum computer system sizes and capabilities grow, and more and more offerings shift to cloud-based ‘Quantum as a Service’ delivery,” Biercuk said.

“It will place us well into industry roadmaps towards 1000 qubit machines, meaning we’ll see some very impressive hardware performance metrics being reported.

“We’ll also likely be a bit overwhelmed by continuing claims and counterclaims of performance from different manufacturers – all of that will work out in the wash as applications continue to emerge.

“There’s more than enough space in the community for multiple hardware providers, especially as system architectures and software stacks remain an active area of R&D.”.

Ref: https://stockhead.com.au/tech/heres-why-quantum-computing-in-australia-is-set-for-a-breakout-year-in-2021/

ITech IPO : For eligible holders.

 https://www.itechminerals.com.au/projects-and-commodities

Declare: in the portfolios RL, SM

Another note about AXE and IP australias concern about Room tempreture, electron spin and the carbon onions.  found this in nature (2016):

https://www.nature.com/articles/ncomms12232?proof=t

Looks like its at least observed in demonstration?

AXE patent query

Discolsure I own AXE in my personal portfolio.

Fanstaic news for AXE today.

However I have some concerns about the patent and was wondering if It is at all possible that University of NSW has any claim to IP.

Dr Mohammad Choucair PHD was submitted at NSW and appears to be based on synthesis and purification of carbon nano onions.

and the international patent states this is what is applied for:

"Disclosed herein are complexes comprising graphene compositions thereof. Also disclosed herein are methods of synthesising said complexes and compositions, and the use of said complexes and compositions in, for instance, biomolecular sensing."

My concern is that the IP applied for is based on work from his PHD.

Do people think this is a vaild concern or is this a fairly common thing to occur? Or has UNSW sold its "ownership" of the research ?

https://patentscope.wipo.int/search/docs2/iasr/WO2020163921/html/xkjje5PdTkK4dY6qbi-AQ76-udatxVdDuzFa8ZBl_AhRU8G0iRYbPM9RJa7DS15lUSwgJ0ghfWaJWeVDelhx60QqraiJyBFxYIPHqZQrTilNU62W4loxKh5RdQ5_rNXz

his phd is easily available online.

Chinese patent granted 

• Major commercial milestone reached with the grant of a patent protecting the 12CQ quantum computing chip in the world’s second largest economy.

• Chinese patent for the 12CQ chip is a significant validation of the technology’s industrial and technical global competitive advantage.

• China has over 2.6 million patents in force, second only to the US, with foreign patent applications mostly from the US, making China one of the biggest innovation economies in the world.

• Archer is the only ASX listed company and one of a few players in the world developing a qubit processor chip in the quantum computing industry†.

For those who want to find out more about Quantum Computing.

This is the exec summary of a bigger OFCOM report available on the OFCOM webpage

Archer Materials - continues its positive steps forward for the building advanced semi conductor chips for Quantum computing. 

This is a very interesting company - It has had some promising commentary latley on Ausbiz etc and now has released more positive news, I recommend taking a look and doing some deep research, it has some global backers most notably IBM and could possibly be anything. 

Stock is going off today based on the news attached.

Disc - I do hold shares personally and got in around 87c mark after researching as i like the semi conductor industry as a whole theme. I believe $1.18+ is immediate upside but who knows where this ends up in the future.  

Company - Archer is a technology company that builds advanced semiconductor devices, including processor chips that are relevant to quantum computing. Archer’s 12CQ is a world-first qubit processor technology that would allow for mobile quantum computing powered devices.

It's time to get to understand the term "Quantum Computer" and maybe "qubit" also, at least enough to use them sensibly in a sentence. I think that in the very near future these will be getting thrown around just like Neuromorphic and blockchain are today. Remember when those words were obscure.

I look forward to a future were quantum computers are in common use extracting  meaningful data from seeming noise.

The following has a lot of good written over it: big company involvement and getting the news out.

Archer and IBM sign new quantum computing agreement

Sale of all mineral tenements

Highlights

• Archer executes a legally binding agreement to sell all of the company's mineral tenements ("Tenements").
• At completion of the sale, Archer will receive 50 million shares in the capital of the buyer ("Share Consideration").
• Share Consideration to be distributed in-specie to Archer shareholders.
• Tenement sale and purchase is subject to certain conditions precedent, including the buyer listing on ASX and Archer shareholders' approval of the transaction and the Share Consideration distribution.
• The buyer expects to list on ASX before September 2021.
• The Company’s business is simplified with Archer to become a pure play deep technology company.

Archer strengthens biochip nanofabrication capabilities

https://www.asx.com.au/asxpdf/20210322/pdf/44tw244wjmf31p.pdf

Highlights:-

•  Key biosensor components of Archer’s lab-on-a-chip device miniaturised to nanosize chip formats, a requirement for successful biochip development.
•  Archer team grows, introducing world-class expertise and capabilities spanning nanotechnology, advanced materials, and molecular biology.
•  The Company is utilising over $150 million of sophisticated chip building facilities in Australia to manufacture its graphene-based biochip technology.
•  Lab-on-a-chip devices form part of the multibillion dollar deep-tech economy, catalysed by the global need for point of care medical diagnostics and testing

DISC: I hold

Appears the market liked the AXE update, closing on its high of the day up 50%! Nothing changed for me, I am just sitting tight with the stock in the bottom draw. (Diamond hands I believe the kids call it)

As I said in a previous straw It remains a back the jockey story, in the case a very smart and motivated jockey named Mohammed.

What a day for AXE. I was alerted to this little gem in Jan 2018 when it was .16. Oh how odd listened to the ramblings of an old man when he told me this was going to the moon.  Then again, how many times I have listened and, like a fool and his money,  we parted ways.  To those who were along for the ride,  well played and enjoy.  

This is placed to be one of the standout investments of 2021 I believe.  

• Archer achieves a key technological milestone in the development of its 12CQ quantum computing qubit processor chip technology.

• The work represents a significant technical achievement because the electronic transport measurements were performed on a single qubit – only a few hundred atoms across – and at room temperature.

• The Company utilised over $150 million of semiconductor foundry facilities and some of the most advanced instrumentation in the world to complete its most recent validation of the 12CQ technology.

• Archer is one of only a few players† developing a qubit processor chip in the emerging multibillion-dollar quantum computing industry‡.

First patent granted for 12CQ quantum computing chip Highlights

• Japanese patent granted for Archer’s 12CQ quantum computing qubit processor (“chip”).

• Major commercial milestone achieved with the grant of a patent protecting the 12CQ chip technology in a Top 5 global economy.

• Archer is one of few key players† developing a qubit processor chip in the emerging multibillion-dollar quantum computing industry‡. 

The JP Patent (Patent No. 6809670) is the first granted patent protecting the 12CQ chip. The grant of the JP Patent represents a significant commercial milestone in Archer’s development of the 12CQ chip.

The grant of the JP Patent gives Archer access to the high-value Japanese market for the 12CQ chip and is the first step in the Company’s efforts to access global markets. The JP Patent application successfully underwent substantive examination procedures in Japan by the Japan Patent Office§ , which is one of the world’s largest patent offices.

The success in the grant of the JP patent streamlines the patent granting process and procedures for the additional six international patent applications in the jurisdictions of Australia, South Korea, Hong Kong, China, Europe, and the US (ASX ann. 6 Oct 2020). The Company considers Japan as a critical strategic jurisdiction to protect and commercialise its IP. Japan is a major global economy** and according to the World Economic Forum, ranks amongst the top 5 economies in the world for global competitiveness and GDP.

Commenting on the grant of the Japanese patent, Archer CEO Dr Mohammad Choucair said: “Archer’s quantum computing chip IP is now well protected in Japan – a major global economy and centre for technological innovation.

The grant of a patent in Japan further validates, and substantially derisks, our unique technology. “Archer is one of very few companies in the world with a patent portfolio protecting quantum computing qubit processor technology, and this is strategically significant as we rapidly progress in commercialising the 12CQ chip.”

Australian Semiconductor Sector Study

Archer Materials Limited (ASX: AXE) is pleased to inform shareholders that the Office of the NSW Chief Scientist & Engineer has published a comprehensive independent report, titled Australian Semiconductor Sector Study: Capabilities, opportunities and challenges for NSW’s meaningful participation in the global semiconductor value chain. Archer contributed to the development of the Scoping Study, together with other semiconductor sector leaders.

The Company encourages shareholders and investors to read the Scoping Study as it examines the global semiconductor market size and current and future trends, analyses NSW and Australian performance and capabilities to date, offers recommendations on what is needed for the sector’s constituents in NSW to successfully accelerate their participation in the high-value high-tech semiconductor industry, and prospective global market opportunities where Australian companies may hold a leading position, for example in Quantum Computing.

The Scoping Study identifies the largest areas of opportunity for the scaleup of companies, such as Archer, in the global semiconductor industry. These areas include enhancing domestic capability in semiconductor design, fabrication and prototyping. In particular, as it relates to the commercial translation of advanced materials and quantum computing technology.

The Scoping Study presents a positive long-term outlook for the potential of increased participation by companies such as Archer in the global semiconductor sector. Archer’s current areas of strength and strategic significance across the semiconductor value chain is reported to include securing high-impact intellectual property in global markets and chip development.

I haven't read it all yet, but I think a few of you might find it interesting. It is 48 pages...copy & paste

https://www.chiefscientist.nsw.gov.au/__data/assets/pdf_file/0005/339647/Australian-Semiconductor-Sector-Study.pdf

Company is making plays in great macro trend areas and has some impressive ties with big corps, I think it's time to start taking this company serious and scale in for the potential of huge upside.

Quantum collaboration with leading AI firm Max Kelsen
Highlights
• Archer and Max Kelsen will develop quantum algorithms relevant to the
operation of the 12CQ quantum computing processor (“chip”).
• The Australian companies are members of the IBM Q Network†, and will use
IBM’s Qiskit and quantum computers for testing and validation.
• The collaboration is a key step in the commercialisation of the 12CQ chip,
and aims to validate chip end-uses and high-value practical applications.
• Quantum computing outcomes from the collaboration will target multiple
sectors, including ICT and financial services‡.
Archer Materials Limited (“Archer”, the “Company”, “ASX: AXE”) is pleased to announce that it
has entered into a collaboration with a leading Artificial Intelligence and Machine Learning
company, Max Kelsen (“the Collaboration”). Archer and Max Kelsen are members of the global
IBM Q Network†
.
The collaboration is a critical step in the commercialisation of the 12CQ chip because the
principal purpose of building quantum computing processors is to apply and run quantum
algorithms to generate value from outperforming modern computing.
Commenting on the collaboration, Archer CEO Dr Mohammad Choucair said: “As part of
Archer’s forward looking strategy, the partnership with Max Kelsen – a leading AI and Quantum
Computing firm – is a key step forward in the commercialisation of our 12CQ chip technology.
“It’s a great example of how two Australian IBM Q Network Members are working together to
realise the commercial potential of quantum computing.
“We will use IBM’s Qiskit and quantum machines to validate our work, and once validated,
Archer intends to apply the end-user cases, algorithms and Qiskitto 12CQ chip hardware, which
demonstrates the increasing value our partnerships bring as we progress in our development.”
As IBM Q Network members, Archer and Max Kelsen will use IBM’s Qiskit open source
programming framework and cloud-based quantum computers to implement novel quantum
algorithms developed that validate practical quantum computing applications relevant to
Archer’s 12CQ chip technology, i.e. real uses that would benefit from quantum processors
onboard technology at room temperature.
† https://www.nature.com/articles/s42254-020-00247-5; also https://www.ibm.com/quantumcomputing/network/members/
‡ https://www.bcg.com/en-au/publications/2020/how-financial-institutions-can-utilize-quantum-computing
Advanced Materials Archer Materials Limited (ACN: 123 993 233)
12CQ Ground Floor, 28 Greenhill Road, SA 5034
As part of the Collaboration, Archer staff will work directly with the quantum computing team
at Max Kelsen to develop industrially relevant business use-cases of the 12CQ technology for a
number of sectors with the potential for high-value add, including finance‡ and
telecommunications§
. This will involve the use of quantum processors to run quantum
algorithms that have real applications such as Quantum Artificial Neural Networks.
About 12CQ
12CQ is a world-first quantum processor technology that Archer aims to build for quantum
computing operation at room-temperature and integration onboard modern electronic devices.
For more information, please view Archer’s a recent webinar held with IBM.
About Max Kelsen
Founded in Brisbane in 2015, Max Kelsen is a globally leading Artificial Intelligence (AI) and
Machine Learning (ML) software business. Max Kelsen enables innovation directly linked to the
generation of business value and competitive advantage, including for Fortune 500 companies
and some of Australia’s most iconic brands. Max Kelsen’s solutions are at the heart of workflow
automation and value extraction from data, providing extremely accurate predictive modelling
in critical systems like clinical decision making. Max Kelsen is also dedicated to reinvesting its
expertise and profits to solve the challenges of humankind, focusing on Cancer Genomics, AI
Safety, and Quantum Computing. Max Kelsen was the Amazon Web Services (AWS) Partner of
the Year in 2020 for Data and AI

This company keeps on innovating.....announcing 
Archer’s A1 Biochip™ 

• Archer commences its A1 Biochip™ development with the aim of building a lab-on-chip biosensing device capable of simplifying disease detection.

• The A1 Biochip™ is being built by the Archer team in a world-class semiconductor chip prototyping foundry.

• Archer is working with a German biotech company to explore the on-chip conversion of in-demand commercial diagnostics.

• Lab-on-chip devices form part of the global multibillion dollar biotech economy, catalysed by advances in point of care diagnostics and testing1.

• Archer owns all the IP associated to the biochip technology, and the Company is prosecuting related international patent applications.  

Archer Materials Limited (“Archer”, the “Company”, “ASX: AXE”) is pleased to announce the Company has commenced building a lab-on-a-chip device (“biochip”) named A1 Biochip™.

Archer has made a step-change in advancing its graphene-based biosensor technology development to newly commence its lab-on-a-chip A1 Biochip™ project. This was possible in a short period of time as Archer brought its biotechnology development in-house and is now able
to miniaturise its biosensing processes to chip-formats while retaining its IP.

Archer will be designing and building its own biochip which means that the Company no longer requires prototyping sensor materials, graphene inks, 2D/3D printing, or circuit boards (manufactured in Asia) (ASX Ann. 31 Aug 2020). Developing the biochip in-house should allow Archer to accelerate commercialisation of the biochip.

Commenting on the A1 Biochip™ development, Archer CEO Dr Mohammad Choucair said: “It is a global challenge to develop innovative biodevices that make the complex detection of disease safer and more reliable. Archer’s A1 Biochip™ technology aims to simplify disease detection at the point of care to potentially address an emerging multibillion dollar industry.

“Archer’s biochip development involves miniaturising medical lab tests onto an integrated circuit, a single chip, that is only a few millimetres in size. This is incredibly difficult, and there
are very few people the world that can do this type of work, however Dr Soffe has already made exciting advances on this front in only a few weeks since joining Archer”.

A friend told me about AXE back in late 2019… and like most spec stories I didn’t really listen (silly me.) Then when I saw the agreement with IBM and Share price rocketing I asked him more about it. He works in Corporate Finance and had a one on one with Mohammed. He said he probably the smartest guy he has ever met and he also seems very genuine, passionate and driven by the work in his field not by money.

Quantum Computing is something I know nothing about but this investment is more a case of playing the man not the ball. And Mohammed is the man!

They are currently doing a cap raise via SPP only, Looking after existing holders with no discounted placement to outsiders. I went back through there announcements and they have a good history of treating shareholders well, which is what you want to see when get involved with a speculative play like this.

This is a high risk play and potentially even a company that could go to zero, but if they succeed it could also be 10x the current price.

A high risk/reward Buy.

Archer have developed quantum computing technology allowing chip to function in room temperature, opening possibilities for quantum computing to be utilised in mainstream computers. See ASX announcement below for IBM agreement...

• Archer signs an agreement with IBM to advance quantum computing and work towards solutions for the widescale adoption of the technology. • Archer is the first Australian company building a quantum computing qubit processor to join the global IBM Q Network as an ecosystem partner. • IBM staff will work directly with the Archer team who will gain access to IBM's quantum computing expertise and resources to enable a broader hardware ecosystem using IBM’s open source software framework, Qiskit. • Archer is considerably advancing the commercial readiness of its 12CQ qubit processor chip technology towards a minimum viable product. • The intellectual property rights protecting the 12CQ qubit processor chip technology are exclusively held by Archer.